It is getting late for Sunday, but I would like to once again take a look back a bit further at our selections for the week of 5/19/03. This is our second six-month review; last week we looked at the week of 5/12/03.
The first stock selected for that week was Bradley Pharmaceutical (BDY) on 5/19/03 at $15.77. BDY closed on 11/28/03 at $23.52. This is a gain of $7.75 or 49.1%.
Next on our list, also on 5/19/03 was Genentech (DNA) at $53.04. DNA closed on 11/28/03 at $84.30 for a gain of $31.26 or 58.9%.
Home Depot (HD) was selected on 5/20/03 at $31.10. HD closed on 11/28/03 at $36.76 for a gain of $5.66 or 18.2%.
Synovis Life Tech (SYNO0 was selected on 5/21/03 at $14.39. SYNO closed 11/28/03 at $25.71 for a gain of $11.32 or 78.7%.
Enzo Biochem (ENZ) was selected at $20.40 on 5/22/03. ENZ closed 11/28/03 at $18.45 for a loss of ($1.95) or (9.6%).
Dicks Sporting Goods (DKS) was selected at $29.75 on 5/22/03. DKS closed 11/28/03 at $52.58 for a gain of $22.83 or 76.7%.
New Century Financial (NCEN) was selected on 5/22/03 at $47.02 or $31.50 adjusted for a 3:2 split on 7/14/03. NCEN closed 11/28/03 $38.06 up $6.56 or 20.8%.
NVR Inc. (NVR) was selected at $394.86 on 5/23/03. NVR closed 11/28/03 at $491.00 for a gain of $96.14 or 24.3%.
Finally, Red Robin Gourmet Burger (RRGB) was selected on 5/23/03 at $17.00. RRGB closed 11/28/03 at $26.92 for a gain of $9.92 or 58.4%.
All in all it was a very good week. We had eight stocks appreciating from 18.29% to 78.7% and one stock down (9.62%). The average performance over the last six months for these nine stocks was a gain of 41.73%.
This certainly was a GREAT result. Of these stocks, I did own New Century for a short period and still have some shares of SYNO in my trading account. Please be sure to discuss any of these stocks with your investment advisor before making any investment decisions as they may or may not be profitable for you and may or may not be suitable investments.
Thanks again for stopping by! If you have any questions, please feel free to email me at Bobsadviceforstocks@lycos.com